The Sarco-Endoplasmic Reticulum Ca2+ ATPase Is Required for Development and Muscle Function in Caenorhabditis elegans

• Published in: The Journal of biological chemistry 2001-11, Vol.276 (47), p.43557-43563
• Main Authors: Zwaal, Richard R., Van Baelen, Kurt, Groenen, José T.M., van Geel, Anton, Rottiers, Veerle, Kaletta, Titus, Dode, Leonard, Raeymaekers, Luc, Wuytack, Frank, Bogaert, Thierry
• Format: Article
• Language: English
• Subjects: Animals; Base Sequence; Caenorhabditis elegans - enzymology; Caenorhabditis elegans - growth & development; Caenorhabditis elegans - physiology; Calcium-Transporting ATPases - antagonists & inhibitors; Calcium-Transporting ATPases - metabolism; COS Cells; DNA Primers; Enzyme Inhibitors - pharmacology; Larva - growth & development; Muscles - physiology; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Thapsigargin - pharmacology
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.M104693200

The sarco-endoplasmic reticulum Ca2+-transport ATPase (SERCA) loads intracellular releasable Ca2+ stores by transporting cytosolic Ca2+ into the endoplasmic (ER) or sarcoplasmic reticulum (SR). We characterized the only SERCA homologue of the nematode Caenorhabditis elegans, which is encoded by the sca-1 gene. The sca-1 transcript is alternatively spliced in a similar mode as the vertebrate SERCA2 transcript, giving rise to two protein variants: CeSERCAa and CeSERCAb. These proteins showed structural and functional conservation to the vertebrate SERCA2a/b proteins. The CeSERCAs were primarily expressed in contractile tissues. Loss of CeSERCA through gene ablation or RNA interference resulted in contractile dysfunctioning and in early larval or embryonic lethality, respectively. Similar defects could be induced pharmacologically using the SERCA-specific inhibitor thapsigargin, which bound CeSERCA at a conserved site. The conservation of SERCA2 homologues in C. elegans will allow genetic and chemical suppressor analyses to identify promising drug targets and lead molecules for treatment of SERCA-related diseases such as heart disease.